FundedStartupsDaily / HealthTech / Undecimal Bio

Undecimal Bio raises $18M

Undecimal Bio announced a Seed round of $18M on 13 October 2026. The company operates in HealthTech and is based in United Kingdom. It was founded by Yaniv Erlich, CEO & Co-founder. Announced yesterday.

Raised
$18M
Stage
Seed
Industry
HealthTech
Country
United Kingdom

Founder

Yaniv Erlich
CEO & Co-founder, Undecimal Bio
LinkedIn profileundecimalbio.com

Outreach angles

  • -Yaniv Erlich is CEO and co-founder of Undecimal Bio, a spin-out from Eleven Therapeutics.
  • -Erlich co-founded Undecimal with Shaul Ilan and a board that includes 4BIO Capital, IQ Capital and Harel Technologies.
  • -The Seed expands the DELiveri AI platform, advances renovascular programmes and grows the team at the Cancer Research UK Cambridge Institute labs.

Signals

SeedDeep TechAI-NativeHealthcareHiringRegulated Industry

Round details

Company: Undecimal Bio
Domain: undecimalbio.com
Amount: $18M
Stage: Seed
Industry: HealthTech
Country: United Kingdom
Announced: 13 October 2026
Source: announcement

Other HealthTech raises

Stride
£4.6M · Seed
SpectaCell
€6M · Seed
Wally
$25M · Series A
Vocca
$20M · Series A
Breye Therapeutics
$79.0M · Series A
Blue Health Intelligence
$4M · Seed

Recently funded in United Kingdom

Obsero
$1.2M · AI & Machine Learning
Affinity Labs
$2M · Consumer
Alchera Technologies
£2.7M · AI & Machine Learning
Neela Biotech
£2.1M · Climate & Energy
Universal Quantum
$100M · Robotics & Hardware
Nettle
$4.8M · FinTech